Yinhong Xiang, Hao Yang, Yani Zhong, Xunuo Ren, Jing Wen, Zhong Wang, Xueshuang Huang, Jianxin Liu, Yong Huang, Hong Pu
{"title":"内生真菌Diaporthe sp. CB10100中未描述的两种吡咯化合物鞣花酸C和aspergone R:生物学评价、分子对接和分子动力学研究。","authors":"Yinhong Xiang, Hao Yang, Yani Zhong, Xunuo Ren, Jing Wen, Zhong Wang, Xueshuang Huang, Jianxin Liu, Yong Huang, Hong Pu","doi":"10.1080/14786419.2025.2565814","DOIUrl":null,"url":null,"abstract":"<p><p>Two new compounds, ellagic acid C (<b>5</b>) and aspergone R (<b>6</b>), along with four previously identified compounds (<b>7-10</b>), were successfully isolated from the fungus <i>Diaporthe</i> sp. CB10100. Ellagic acid C (<b>5</b>) contains an uncommon tricyclic 5/6/6 ring system. A biosynthetic pathway for <b>6</b> was proposed, although additional investigations are needed to elucidate the ethyl biosynthesis mechanism. Both aspergone R (<b>6</b>) and (-)-terpestacin (<b>9</b>) decreased lipopolysaccharide (LPS)-induced protein expression of iNOS and COX-2. Molecular docking analysis revealed that <b>6</b> and <b>9</b> potentially interact with the active sites of iNOS and COX-2. Molecular dynamics simulations demonstrated that, compared with the other compounds, <b>6</b> exhibited increased binding stability and stronger interactions with the COX-2 protein. Furthermore, <b>5-9</b> were effective against MRSA, <i>Klebsiella pneumoniae</i>, and <i>Mycolicibacterium</i> (<i>Mycobacterium</i>) smegmatis, with MICs greater than 64 μg/mL. These findings suggest that <b>6</b> and the common γ-pyrone scaffold could serve lead compounds for anti-inflammatory drug development.</p>","PeriodicalId":18990,"journal":{"name":"Natural Product Research","volume":" ","pages":"1-9"},"PeriodicalIF":1.6000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ellagic acid C and aspergone R, two undescribed pyrones from the endophytic fungus <i>Diaporthe</i> sp. CB10100: biological evaluation, molecular docking and molecular dynamics studies.\",\"authors\":\"Yinhong Xiang, Hao Yang, Yani Zhong, Xunuo Ren, Jing Wen, Zhong Wang, Xueshuang Huang, Jianxin Liu, Yong Huang, Hong Pu\",\"doi\":\"10.1080/14786419.2025.2565814\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Two new compounds, ellagic acid C (<b>5</b>) and aspergone R (<b>6</b>), along with four previously identified compounds (<b>7-10</b>), were successfully isolated from the fungus <i>Diaporthe</i> sp. CB10100. Ellagic acid C (<b>5</b>) contains an uncommon tricyclic 5/6/6 ring system. A biosynthetic pathway for <b>6</b> was proposed, although additional investigations are needed to elucidate the ethyl biosynthesis mechanism. Both aspergone R (<b>6</b>) and (-)-terpestacin (<b>9</b>) decreased lipopolysaccharide (LPS)-induced protein expression of iNOS and COX-2. Molecular docking analysis revealed that <b>6</b> and <b>9</b> potentially interact with the active sites of iNOS and COX-2. Molecular dynamics simulations demonstrated that, compared with the other compounds, <b>6</b> exhibited increased binding stability and stronger interactions with the COX-2 protein. Furthermore, <b>5-9</b> were effective against MRSA, <i>Klebsiella pneumoniae</i>, and <i>Mycolicibacterium</i> (<i>Mycobacterium</i>) smegmatis, with MICs greater than 64 μg/mL. These findings suggest that <b>6</b> and the common γ-pyrone scaffold could serve lead compounds for anti-inflammatory drug development.</p>\",\"PeriodicalId\":18990,\"journal\":{\"name\":\"Natural Product Research\",\"volume\":\" \",\"pages\":\"1-9\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Natural Product Research\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://doi.org/10.1080/14786419.2025.2565814\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, APPLIED\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Natural Product Research","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1080/14786419.2025.2565814","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
Ellagic acid C and aspergone R, two undescribed pyrones from the endophytic fungus Diaporthe sp. CB10100: biological evaluation, molecular docking and molecular dynamics studies.
Two new compounds, ellagic acid C (5) and aspergone R (6), along with four previously identified compounds (7-10), were successfully isolated from the fungus Diaporthe sp. CB10100. Ellagic acid C (5) contains an uncommon tricyclic 5/6/6 ring system. A biosynthetic pathway for 6 was proposed, although additional investigations are needed to elucidate the ethyl biosynthesis mechanism. Both aspergone R (6) and (-)-terpestacin (9) decreased lipopolysaccharide (LPS)-induced protein expression of iNOS and COX-2. Molecular docking analysis revealed that 6 and 9 potentially interact with the active sites of iNOS and COX-2. Molecular dynamics simulations demonstrated that, compared with the other compounds, 6 exhibited increased binding stability and stronger interactions with the COX-2 protein. Furthermore, 5-9 were effective against MRSA, Klebsiella pneumoniae, and Mycolicibacterium (Mycobacterium) smegmatis, with MICs greater than 64 μg/mL. These findings suggest that 6 and the common γ-pyrone scaffold could serve lead compounds for anti-inflammatory drug development.
期刊介绍:
The aim of Natural Product Research is to publish important contributions in the field of natural product chemistry. The journal covers all aspects of research in the chemistry and biochemistry of naturally occurring compounds.
The communications include coverage of work on natural substances of land and sea and of plants, microbes and animals. Discussions of structure elucidation, synthesis and experimental biosynthesis of natural products as well as developments of methods in these areas are welcomed in the journal. Finally, research papers in fields on the chemistry-biology boundary, eg. fermentation chemistry, plant tissue culture investigations etc., are accepted into the journal.
Natural Product Research issues will be subtitled either ""Part A - Synthesis and Structure"" or ""Part B - Bioactive Natural Products"". for details on this , see the forthcoming articles section.
All manuscript submissions are subject to initial appraisal by the Editor, and, if found suitable for further consideration, to peer review by independent, anonymous expert referees. All peer review is single blind and submission is online via ScholarOne Manuscripts.